Financial statements Immbionic
Balance sheet data of IMMBIONIC
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 116 439,94 | 3 807 895,23 | 381 745,31 |
A. Fixed assets | 0,00 | 19 624,95 | 17 629,23 |
B. Current assets | 116 439,94 | 3 788 270,28 | 364 116,08 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
Total liabilities | 116 439,94 | 3 807 895,23 | 381 745,31 |
A. Equity | 103 414,64 | 270 236,64 | 376 243,55 |
B. Liabilities and provisions for liabilities | 13 025,30 | 3 537 658,59 | 5 501,76 |
I. Long-term liabilities | -48,71 | 0,00 | 0,00 |
II. Short-term liabilities | 13 074,01 | 3 472 617,94 | 5 501,76 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.